SPONSOR
NRG Oncology
Total Trials
4
Recruiting
4
Phases
Phase 3, Phase 2, Phase 3
Conditions studied: Grade 2 MeningiomaIntracranial MeningiomaStage I Breast CancerStage III Colon CancerProstate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8
NRG Oncology is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Grade 2 Meningioma, Intracranial Meningioma, Stage I Breast Cancer, Stage III Colon Cancer.
The trial portfolio spans Phase 3, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — NRG Oncology
How many clinical trials has NRG Oncology sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by NRG Oncology, of which 4 are actively recruiting participants. These trials cover conditions including Grade 2 Meningioma, Intracranial Meningioma, Stage I Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does NRG Oncology research focus on?
NRG Oncology clinical trials span Grade 2 Meningioma, Intracranial Meningioma, Stage I Breast Cancer, Stage III Colon Cancer, Prostate Adenocarcinoma, and additional conditions. The research pipeline includes Phase 3, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a NRG Oncology clinical trial?
To participate in a NRG Oncology trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all NRG Oncology trials with current recruitment status updated daily.
Clinical Trials by NRG Oncology
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Grade 2 Meningioma
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
NCT05946213 Phase 3
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology